Short-term outcomes from the ‘Watch and Wait’ (WoW) study: prospective cohort study
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae151 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJS Open, 2024. Verfasst von Daniel Rydbeck und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenb…. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Rectal Neoplasms, Watchful Waiting. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Cancer Society, Swedish Research Council, Mary von Sydow's Foundation.
Abstract (Originalsprache)
Background
Despite absence of level 1 evidence on the long-term oncological safety of non-operative management for rectal cancer (watch and wait), increased implementation has occurred globally over the past decades. In Sweden, a pan-national prospective non-randomized study was initiated in 2017 to assess its implementation.
Method
Patients with biopsy-proven rectal cancer receiving neoadjuvant therapy according to national guidelines in whom a clinical complete response was detected at reassessment were eligible for inclusion following informed consent. Only patients with an opportunistic watch-and-wait approach were included. Inclusion and follow-up, according to the study protocol, was managed at the participating study centres. The primary outcome measure of the study is 3-year disease-free survival. Here, the secondary short-term outcomes local regrowth rate, distant metastasis rate and outcomes after surgery for regrowth, at 6 months follow-up, are reported.
Results
Between January 2017 and February 2023, 211 patients with a clinical complete response were included in the study. Thirty-three (16%) patients developed suspicious regrowth within 6 months of inclusion. Thirty-two of 33 patients had abdominal resectional surgery for regrowth. The curative intention rate was 94% for patients with regrowth. Three patients (1.4%) developed distant metastases within 6 months of inclusion.
Conclusion
This Swedish national study on watch and wait reports regrowth rates after 6 months are in line with previous reports in the literature. Nearly all patients with early regrowth could be treated with salvage surgery and curative intent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenburg, Gothenburg, Sweden.
- Department of Surgery, Region Västra Götaland, Sahlgrenska Universitetssjukhuset, Gothenburg, Sweden.
- Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
- Department of Surgery, Skåne University Hospital, Malmö, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden.
- Department of Radiation Physics/Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Daniel Rydbeck, Eva Angenete
Förderung
- Swedish Cancer Society
- Swedish Research Council
- Mary von Sydow's Foundation
Zitieren
APA
Rydbeck, D., Azhar, N., Blomqvist, L., Chabok, A., Folkesson, J., Gerdin, A., Hermus, L., Matthiessen, P., Martling, A., Nilsson, P. J., & Angenete, E. (2024). Short-term outcomes from the ‘Watch and Wait’ (WoW) study: prospective cohort study. BJS Open. https://doi.org/10.1093/bjsopen/zrae151
Vancouver
Rydbeck D, Azhar N, Blomqvist L, Chabok A, Folkesson J, Gerdin A, et al. Short-term outcomes from the ‘Watch and Wait’ (WoW) study: prospective cohort study. BJS Open. 2024. doi:10.1093/bjsopen/zrae151
BibTeX
@article{Rydbeck2024,
author = {Rydbeck, Daniel and Azhar, Najia and Blomqvist, Lennart and Chabok, Abbas and Folkesson, Joakim and Gerdin, Anders and Hermus, Linda and Matthiessen, Peter and Martling, Anna and Nilsson, Per J and Angenete, Eva},
title = {Short-term outcomes from the ‘Watch and Wait’ (WoW) study: prospective cohort study},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae151}
}
EUVIMED